TEG ® , Microclot and Platelet Mapping for Guiding Early Management of Severe COVID-19 Coagulopathy
Review
[키워드] Activation
addition
Anticoagulant
approach
blood clotting
caused
circulating
circulation
clinical trials
Coagulopathy
consumptive coagulopathy
COVID-19
COVID-19 patient
disease severity
dysfunction
Efficacy
endothelial function
Endothelium
Factor
fibrinolysis
Guiding
highlight
Immune cell
Inflammatory
Interaction
intrinsic
low molecular weight
maintain
management
mapping
outcome
pathway
physiological state
Platelet
platelet activation
Platelets
Prophylactic
receptor
reduced
required
severe COVID-19
severe COVID-19 disease
therapeutic
Trial
von Willebrand factor
vWF
[DOI] 10.3390/jcm10225381 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/jcm10225381 PMC 바로가기 [Article Type] Review